227 related articles for article (PubMed ID: 786297)
1. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
Parker MD; Turner RA
Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
Peltier AP
Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
[No Abstract] [Full Text] [Related]
3. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity of antinuclear antibodies in scleroderma.
Blaszczyk M; Beutner EH; Rogozinski T; Rzesa G; Jarzabek-Chorzelska M; Jablonska S; Chorzelski TP
J Invest Dermatol; 1977 Apr; 68(4):191-3. PubMed ID: 66298
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
Webb J; Whaley K; Lee P
Scott Med J; 1974 Jul; 19(4):171-5. PubMed ID: 4209789
[No Abstract] [Full Text] [Related]
6. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
Zitńan D; Cebecauer L
J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
[No Abstract] [Full Text] [Related]
7. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.
Sharp GC; Irvin WS; LaRoque RL; Velez C; Daly V; Kaiser AD; Holman HR
J Clin Invest; 1971 Feb; 50(2):350-9. PubMed ID: 4992992
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies (ANA): immunologic and clinical significance.
Fernandez-Madrid F; Mattioli M
Semin Arthritis Rheum; 1976 Nov; 6(2):83-124. PubMed ID: 62398
[TBL] [Abstract][Full Text] [Related]
9. [Anti-nuclear antibodies in collagen diseases].
Gintz B; Phelip X; Micouin C; Cabanel G
Sem Hop; 1975 Feb; 51(9):573-80. PubMed ID: 169588
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
Stojan B
Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
[No Abstract] [Full Text] [Related]
11. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
Parker MD; Kerby GP
Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
[No Abstract] [Full Text] [Related]
12. [Studies on differing complement-fixing properties of antinuclear antibodies in the nephropathy of systemic lupus erythematosus].
Tojo T; Miyachi K; Homma M
Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):621-30. PubMed ID: 4565168
[No Abstract] [Full Text] [Related]
13. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns.
Nisengard RJ; Jablonska S; Chorzelski TP; Blaszcyk M; Jarret C; Beutner EH
Arch Dermatol; 1975 Oct; 111(10):1298-300. PubMed ID: 54050
[TBL] [Abstract][Full Text] [Related]
14. The incidence and clinical significance of antibodies to extractable nuclear antigens.
Hamburger M; Hodes S; Barland P
Am J Med Sci; 1977; 273(1):21-8. PubMed ID: 300568
[TBL] [Abstract][Full Text] [Related]
15. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
Mulli JC; Cruchaud A
Int Arch Allergy Appl Immunol; 1977; 53(3):279-89. PubMed ID: 300712
[TBL] [Abstract][Full Text] [Related]
17. Mixed connective tissue disease in childhood. A clinical and serologic survey.
Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
[TBL] [Abstract][Full Text] [Related]
18. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
[No Abstract] [Full Text] [Related]
19. Antinuclear antibodies. Clinical significance of titers and fluorescence patterns.
Husain M; Neff J; Daily E; Townsend J; Lucas F
Am J Clin Pathol; 1974 Jan; 61(1):59-65. PubMed ID: 4128966
[No Abstract] [Full Text] [Related]
20. [Antibodies against various nuclear antigens (especially DNA and RNA proteins) in disseminated lupus erythematosus with and without kidney involvement and in other collagen diseases. Preliminary report].
Mulli JC; Cruchaud A
Schweiz Med Wochenschr; 1975 Dec; 105(50):1724-5. PubMed ID: 1082642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
